Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of intravenous lidocaine and magnesium sulfate on reduction of myoclonic movements
IRCT2017062134674N1Phase 3Completed
- Sponsor
- Shahroud University of Medical Sciences
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in myoclonus comparing Intravenous lidocaine with Intravenous magnesium sulfate (2 arms). Primary endpoint: Reduction in myoclonic movements. Started Jul 2017; status: completed.
02
Drugs
lidocainemagnesium sulfate
03
Conditions
myoclonus
Beyond the preview
Go deeper on IRCT2017062134674N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017062134674N1.